Table: Aska Pharmaceutical -2015/16 group forecast
Apr 25 (Reuters) -
Aska Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2016 Mar 31, 2016
LATEST PREVIOUS
FORECAST FORECAST
Sales 43.21 44.00
Operating 1.16 800 mln
Recurring 1.52 1.00
Net 700 mln 600 mln
EPS 25.15 yen 21.53 yen
NOTE - Aska Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on ASKA Pharmaceutical Holdings
See all newsTable: Aska Pharmaceutical Holdings -Q1 group results
Brief: Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25
Brief: Aska Pharmaceutical -Plan To Put To Shareholders Proposal On Countermeasures Against Potential Large-Scale Share Purchase By Dalton And Related Parties
Table: Aska Pharmaceutical Holdings -2025/26 group results
Table: Aska Pharmaceutical Holdings -2025/26 group results